Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Cost of Revenue
$591.00K
Quarterly · Period ending: · USD
ARMP Cost of Revenue
Latest reported$591.00Kperiod ending
Latest reported$591.00Kperiod ending
ARMP Quarterly Cost of Revenue ($0.00 → $591.00K)
Quarterly cost of revenue
High-resolution chart · PNG
ARMP cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 591,000 | |
| 457,000 | |
| 0 | |
| 0 | |
| 366,000 | |
| 377,000 | |
| 380,000 | |
| 313,000 | |
| 315,000 | |
| 317,000 | |
| 293,000 | |
| 221,000 | |
| 200,000 | |
| 9,604,000 | |
| 9,569,000 | |
| 8,400,000 | |
| 9,020,000 | |
| 8,028,000 | |
| 4,814,000 | |
| 5,626,000 | |
| 5,225,000 | |
| 4,350,000 | |
| 4,980,000 | |
| 4,066,000 | |
| 2,648,000 | |
| 0 | |
| 302,000 | |
| 0 | |
| 0 | |
| 0 | |
| 98,000 | |
| 0 | |
| 0 | |
| 97,000 | |
| 96,000 | |
| 93,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -610,000 | |
| -435,000 | |
| -378,000 | |
| -353,000 | |
| -500,000 | |
| -400,000 | |
| -300,000 | |
| -400,000 | |
| -400,000 | |
| -300,000 | |
| -500,000 |